Cathie Wood: This Changes Everything - This Stock Can 10x

Link to Join on Patreon
I am very excited to share my findings with you today… I believe I have found a stock that can surprise the whole investment community. Market is currently unable to value their new and better gene editing technology. But that is about to change soon.
Quick announcement I will provide update on Cara Therapeutic at the end of the video…
You must have heard of Crisper Gene Editing technology… What if I tell you that Editas Medicine Incorporated ticker symbol EDIT has developed a better gene editing technology that addresses all the deficiencies of Crisper gene editing technology…. Once market realize the true potential of their Technology it would be too late. Editas can provide 10x returns in long term… Cathie Wood is buying the dips on this stock… BlckRock and Vanguard group has bought a significant chunk of this company…
Listen carefully and don’t skip please because this information could be worth billions to many high profile investors… and we too can benefit from an early stock entry…
Name of Editas new gene editing technique is “Sleek” SeLection by Essential-gene Exon Knock-in.
But at the moment Crisper Is used for gene editing, Term Crisper refers to a gene editing technology that can revise, remove, and replace DNA in a highly targeted manner. But it had a major flaw and that was low efficiency in Gene Knock Ins, meaning after the removal of flawed gene the insertion of new perfect gene was never 100% efficient….
But now Editas has developed a new Gene Editing technique called “Sleek” that has 100% Gene Knock In rates.
Listen to what Mark S. Shearman, Executive Vice President and Chief Scientific Officer of Editas Medicine said about their new Sleek gene editing technology.
“We find the new gene editing SLEEK technology to have immense potential, as it enables nearly 100 percent knock-in of functional transgene cargos at specific locations in the genome, which we believe to be the highest in the gene editing field across multiple cell types. We believe that this novel technology has broad applications and may result in substantially improved gene edited cell medicines, including for novel CAR-T and CAR-NK cell therapies,”
I think this is a huge breakthrough in gene editing technology.

DISCLAIMER: Note that I am not a financial adviser and you should do your own due diligence before making any decision. I just share my views. I do not recommend basing any investment decisions on my videos. My videos are only made for educational and entertainment purposes.

[zarksnider]

What is ur analysis of SAVA after the critical report on the company?

[busybeelearning]

Please do an update on SAVA, bad news… ?

[chiranshgaur]

U have stopped talking about sava? Is it still bullish?

[rezarahat]

Every single stock in your discord and youtube channel is down at least %40 since last year. Please stop deceiving people.. we all know about SAVA and Crisper

[yellowsnow]

Similar voice called me about my social security being suspended.

[thenlightn]

I've believed in EDIT for a long time now. Glaf you're putting a spotlight on it.